Li, Bob T <br/><br/>
HER2 insertion YVMA mutant lung cancer: Long natural history and response to afatinib.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  Dec 2015 
 - 617-9 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1872-8332 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2015.10.025  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Afatinib<br/>Antineoplastic Agents--therapeutic use<br/>Humans<br/>Immunohistochemistry<br/>Lung Neoplasms--diagnosis<br/>Male<br/>Middle Aged<br/>Mutagenesis, Insertional<br/>Protein Kinase Inhibitors--therapeutic use<br/>Quinazolines--therapeutic use<br/>Receptor, ErbB-2--antagonists & inhibitors<br/>Tomography, X-Ray Computed<br/>Treatment Outcome